October 2024

Precise Health

Precise Health is a biotech startup aiming to revolutionize the treatment of bacterial infections by replacing broad-spectrum antibiotics with personalized bacteriophage technology – starting with inflammatory skin conditions.

Precise Health platform’s leverages the specificity and selectivity of bacteriophages, microorganisms able to target and eliminate harmful bacteria while preserving the beneficial microbiota hence significantly reducing the likelihood of developing antimicrobial resistance.

Ninsun Biotech

Monthey Resident / By Frédérique Brunner

Ninsun Biotech is a start-up based in Valais at BioArk. It operates in the field of oncology and is revolutionising the marking of cancer stem cells by offering, for the first time, a specific biomarker for several cancers, including lung, breast and colon. Current technologies rely on the use of a combination of non-specific markers, so Ninsun Biotech is breaking new ground with its patented technology, offering new prospects in terms of diagnosis, monitoring (companion tests) and, ultimately, individualised treatment for patients. Ninsun Biotech’s stem cell marking kits are also perfectly compatible with the current clinical chain of patient management.